A. Scafidi

发表

Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma

G. Del Baldo, A. Gallo, V. Cesarini, 2020, Molecules.

MicroRNA Editing Detection and Function: A Combined In Silico and Experimental Approach for the Identification and Validation of Putative Oncogenic Targets.

A. Gallo, V. Cesarini, D. A. Silvestris, 2021, Methods in molecular biology.

Elucidating tumour‐associated microglia/macrophage diversity along glioblastoma progression and under ACOD1 deficiency

S. Niclou, A. Poli, A. Oudin, 2022, Molecular oncology.

Glioblastoma-instructed microglia transit to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts

B. Klink, S. Niclou, A. Poli, 2023, bioRxiv.

Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice

F. Azuaje, G. Dittmar, T. Michel, 2022, Allergy.

PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target

A. Poli, A. Michelucci, A. Scafidi, 2023, Journal of Neuroinflammation.

PARK7/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation

A. Ginolhac, A. Michelucci, D. Coowar, 2024, Journal of Neuroinflammation.

Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts

A. Oudin, P. Nazarov, A. Muller, 2024, Genome medicine.

Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts

B. Klink, S. Niclou, A. Poli, 2023, bioRxiv.